NO314168B1 - Farmasöytisk kombinasjon og anvendelse av denne for fremstilling av et medikament - Google Patents

Farmasöytisk kombinasjon og anvendelse av denne for fremstilling av et medikament Download PDF

Info

Publication number
NO314168B1
NO314168B1 NO19970632A NO970632A NO314168B1 NO 314168 B1 NO314168 B1 NO 314168B1 NO 19970632 A NO19970632 A NO 19970632A NO 970632 A NO970632 A NO 970632A NO 314168 B1 NO314168 B1 NO 314168B1
Authority
NO
Norway
Prior art keywords
compound
hiv
combination
pharmaceutically acceptable
treatment
Prior art date
Application number
NO19970632A
Other languages
English (en)
Norwegian (no)
Other versions
NO970632L (no
NO970632D0 (no
Inventor
Paul J Deutsch
Emilio A Emini
Joseph P Vacca
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of NO970632D0 publication Critical patent/NO970632D0/no
Publication of NO970632L publication Critical patent/NO970632L/no
Publication of NO314168B1 publication Critical patent/NO314168B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO19970632A 1994-08-11 1997-02-11 Farmasöytisk kombinasjon og anvendelse av denne for fremstilling av et medikament NO314168B1 (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US28947494A 1994-08-11 1994-08-11
US33936994A 1994-11-14 1994-11-14
US49246195A 1995-07-20 1995-07-20
PCT/US1995/009956 WO1996004913A1 (fr) 1994-08-11 1995-08-07 Combinaison de l'inhibiteur de la protease du vih

Publications (3)

Publication Number Publication Date
NO970632D0 NO970632D0 (no) 1997-02-11
NO970632L NO970632L (no) 1997-04-10
NO314168B1 true NO314168B1 (no) 2003-02-10

Family

ID=27403895

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19970632A NO314168B1 (no) 1994-08-11 1997-02-11 Farmasöytisk kombinasjon og anvendelse av denne for fremstilling av et medikament

Country Status (19)

Country Link
EP (1) EP0774969B8 (fr)
JP (1) JPH10504036A (fr)
KR (1) KR970704441A (fr)
CN (1) CN1101190C (fr)
AT (1) ATE232727T1 (fr)
AU (1) AU698664B2 (fr)
CA (1) CA2197207C (fr)
CY (1) CY2360B1 (fr)
CZ (1) CZ292577B6 (fr)
DE (1) DE69529678T2 (fr)
DK (1) DK0774969T3 (fr)
ES (1) ES2190456T3 (fr)
HU (1) HUT76540A (fr)
IL (1) IL114808A (fr)
MX (1) MX9701121A (fr)
NO (1) NO314168B1 (fr)
PL (1) PL181578B1 (fr)
SK (1) SK18197A3 (fr)
WO (1) WO1996004913A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA49803C2 (uk) * 1994-06-03 2002-10-15 Дж.Д. Сьорль Енд Ко Спосіб лікування ретровірусних інфекцій
US6037157A (en) * 1995-06-29 2000-03-14 Abbott Laboratories Method for improving pharmacokinetics
WO1998020888A1 (fr) * 1996-11-08 1998-05-22 Japan Energy Corporation Medicament contre le sida

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US517041A (en) * 1894-03-27 Fruit-picker
CA1340588C (fr) * 1988-06-13 1999-06-08 Balraj Krishan Handa Derive d'aminoacides
WO1992008698A1 (fr) * 1990-11-19 1992-05-29 Monsanto Company Inhibiteurs de proteases retrovirales
ATE196759T1 (de) * 1990-11-19 2000-10-15 Monsanto Co Inhibitoren retroviraler proteasen
IE20010533A1 (en) * 1990-11-20 2003-03-05 Abbott Lab Intermediates for preparing retroviral protease inhibiting compounds
ATE163926T1 (de) * 1991-11-08 1998-03-15 Merck & Co Inc Hiv-protease-inhibitoren verwendbar in der aids- behandlung
CA2170020C (fr) * 1992-12-29 2005-08-02 Dale J. Kempf Composes inhibant la protease retrovirale

Also Published As

Publication number Publication date
JPH10504036A (ja) 1998-04-14
CZ292577B6 (cs) 2003-10-15
MX9701121A (es) 1997-05-31
EP0774969A1 (fr) 1997-05-28
NO970632L (no) 1997-04-10
ATE232727T1 (de) 2003-03-15
AU3361195A (en) 1996-03-07
NO970632D0 (no) 1997-02-11
IL114808A0 (en) 1995-12-08
WO1996004913A1 (fr) 1996-02-22
SK18197A3 (en) 1997-09-10
CY2360B1 (en) 2004-06-04
KR970704441A (ko) 1997-09-06
HUT76540A (en) 1997-09-29
AU698664B2 (en) 1998-11-05
PL318506A1 (en) 1997-06-23
DE69529678T2 (de) 2003-09-25
DE69529678D1 (de) 2003-03-27
DK0774969T3 (da) 2003-03-31
CA2197207A1 (fr) 1996-02-22
CN1160350A (zh) 1997-09-24
CZ38997A3 (en) 1997-11-12
CN1101190C (zh) 2003-02-12
EP0774969B1 (fr) 2003-02-19
ES2190456T3 (es) 2003-08-01
IL114808A (en) 1999-10-28
CA2197207C (fr) 2006-10-17
PL181578B1 (pl) 2001-08-31
EP0774969B8 (fr) 2003-07-02

Similar Documents

Publication Publication Date Title
DE69534549T2 (de) Kombination von retroviralen Proteasehemmern
US5578597A (en) Combination therapy for HIV infection
KR20080081358A (ko) Ｈｉｖ 인테그라제 억제제의 약동학을 개선하기 위한 방법
DE69628819T2 (de) Kombinationstherapie der hiv-infektion unter verwendung des hiv-protease inhibitors indinavir und des inhibitors der reversen transkriptase 3 tc zusammen mit azt.
NO326719B1 (no) Farmasøytiske blandinger, samt anvendelse og fremgangsmåte for fremstilling derav.
AU2002332610B2 (en) Use of atazanavir in HIV therapy
NO314168B1 (no) Farmasöytisk kombinasjon og anvendelse av denne for fremstilling av et medikament
AU2002332610A1 (en) Use of atazanavir in HIV therapy
DE69806062T2 (de) Kombinationstherapie zur behandlung von aids
AU2863895A (en) Combination therapy for hiv infection
RU2320347C2 (ru) Синергетическое взаимодействие абакавира и аловудина
RU2194506C2 (ru) Сочетание ингибиторов вич-протеазы
JP2006514045A (ja) チプラナビル及びカプラビリンの組み合せ投与によるｈｉｖ感染症の処置
CZ20001752A3 (cs) Farmaceutické prostředky obsahující kombinaci pro léčbu AIDS
CN1118142A (zh) 逆转录病毒抑制剂组合物
JP2018534322A (ja) Ｈｉｖ成熟阻害剤製剤
HK1004659B (en) Combination therapy for hiv infection using the hiv protease inhibitor indinavir and the reverse transcriptase inhibitor 3tc together with azt